TScan Therapeutics TCRX
NASDAQ TCRX
$0.32 +0.00 (+0.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

TScan Therapeutics (TCRX) Total Current Liabilities (2020 - 2026)

Updated

TScan Therapeutics (TCRX) recorded Total Current Liabilities of $30.96 million in Q2 2026, down 1.1% from $31.32 million a year earlier but up 55.1% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, TScan Therapeutics reported Total Current Liabilities of $18.7 million, down 48.0% from FY2024.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of 1.4% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $35.96 million in FY2024 (+20.6%), $29.82 million in FY2023 (+72.3%), $17.31 million in FY2022 (-18.9%) and $21.34 million in FY2021 (+22.3%).
  • Quarterly Total Current Liabilities has ranged from $14.05 million in Q1 2023 to $38.57 million in Q2 2024 over the past five years.
  • On a year-over-year basis, Total Current Liabilities has declined for three consecutive quarters, with an average decline of 12.2% over the last eight quarters.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 124.1% in Q1 2024, against a decline of 48.0% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $19.97 million (Q1 2026), $18.7 million (Q4 2025) and $29.21 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 54.90 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 41.64 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -31.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.02 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.94 Bn
10 TScan Therapeutics 40.28 Mn 40.28 Mn - 30.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.96 Mn
Mar 31, 2026 19.97 Mn
Dec 31, 2025 18.70 Mn
Sep 30, 2025 29.21 Mn
Jun 30, 2025 31.32 Mn
Mar 31, 2025 29.82 Mn
Dec 31, 2024 35.96 Mn
Sep 30, 2024 28.66 Mn
Jun 30, 2024 38.57 Mn
Mar 31, 2024 31.48 Mn
Dec 31, 2023 29.82 Mn
Sep 30, 2023 33.15 Mn
Jun 30, 2023 35.12 Mn
Mar 31, 2023 14.05 Mn
Dec 31, 2022 17.31 Mn
Sep 30, 2022 16.59 Mn
Jun 30, 2022 17.17 Mn
Mar 31, 2022 18.47 Mn
Dec 31, 2021 21.34 Mn
Sep 30, 2021 22.94 Mn
API Access

TScan Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=TCRX&period=max&api_key=YOUR_API_KEY